New Treatments for Non-Communicable Diseases Launched in Uganda

New Treatments for Non-Communicable Diseases Launched in Uganda

allafrica.com

New Treatments for Non-Communicable Diseases Launched in Uganda

C&D Pharma launches three innovative treatments for non-communicable diseases in Uganda with support from the Ministry of Health and other partners.

English
Nigeria
HealthPublic HealthHealthcarePharmaceuticalsUgandaDisease Treatment
C&D PharmaMinistry Of Health (Uganda)Joint Medical Stores (Jms)Kamcare
Dr. Charles OlaroChirag VoraDr Emmanuel Higenyi
What new treatments did C&D Pharma launch in Uganda?
C&D Pharma launched three new treatments for non-communicable diseases in Uganda: Cliniplan Trio for hypertension, Dairetin Family for diabetes, and Daptide for diabetes and hypertension.
Which organizations supported the launch of these new treatments?
The Ugandan Ministry of Health, Joint Medical Stores (JMS), and KAMCARE supported the launch, aiming to improve access to affordable treatments for hypertension, diabetes, kidney disease, and cardiovascular diseases.
What is C&D Pharma's commitment to improving healthcare in Uganda?
C&D Pharma aims to improve health and well-being in Uganda through partnerships with the Ministry of Health, JMS, and KAMCARE, ensuring wider access to the new treatments, even in remote areas.
What are the goals of introducing these new therapies to the Ugandan market?
The new treatments are designed to manage symptoms and prevent long-term complications, reducing the burden on healthcare resources and improving patient outcomes. They aim to alleviate the pill burden and reduce costs for families.
What is the expected impact of these new treatments on Uganda's healthcare system?
The introduction of these therapies is expected to have a significant impact on Uganda's healthcare system, improving efficiency and resource allocation by reducing emergency care and hospitalizations.